Davidson Kempner Will Not Be Tendering Into The Current Offer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailLONDON, Aug. 6, 2020 /PRNewswire/ -- Davidson Kempner notes Thermo Fisher Scientific's statement dated 4 August 2020 and reiterates its position that it considers the current offer wholly inadequate and will not be tendering its shares.
For media enquiries: Greenbrook Andrew Honnor, Rob White, Fanni Bodri Email: [email protected] Tel: +44 (0) 20 7952-2000
View original content:http://www.prnewswire.com/news-releases/davidson-kempner-will-not-be-tendering-into-the-current-offer-301107823.html
SOURCE Davidson Kempner
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SHEIN Further Expands Marketplace Seller Compliance Education With Joint Training Session by US-Based UL Solutions
- Meet the Nov 2 Deadline Risk-Free: ezAccounting Software Automates Q3 IRS Form 941 E-Filing and Core Business Operations
- LUNGevity Invests $1M+ in High-Priority Research to Expand Lung Cancer Workforce & Improve Patient Care
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Davidson Kempner Capital ManagementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
